CoChat

Histone variant H3.3 provides the heterochromatic H3 lysine 9 tri-methylation mark at telomeres

Open access

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Abstract

In addition to being a hallmark at active genes, histone variant H3.3 is deposited by ATRX at repressive chromatin regions, including the telomeres. It is unclear how H3.3 promotes heterochromatin assembly. We show that H3.3 is targeted for K9 trimethylation to establish a heterochromatic state enriched in trimethylated H3.3K9 at telomeres. In H3f3a(-/-) and H3f3b(-/-) mouse embryonic stem cells (ESCs), H3.3 deficiency results in reduced levels of H3K9me3, H4K20me3 and ATRX at telomeres. The H3f3b(-/-) cells show increased levels of telomeric damage and sister chromatid exchange (t-SCE) activity when telomeres are compromised by treatment with a G-quadruplex (G4) DNA binding ligand or by ASF1 depletion. Overexpression of wild-type H3.3 (but not a H3.3K9 mutant) in H3f3b(-/-) cells increases H3K9 trimethylation level at telomeres and represses t-SCE activity induced by a G4 ligand. This study demonstrates the importance of H3.3K9 trimethylation in heterochromatin formation at telomeres. It provides insights into H3.3 function in maintaining integrity of mammalian constitutive heterochromatin, adding to its role in mediating transcription memory in the genome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gkv847

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. H3.3 deficiency results in a compromised heterochromatic state at telomeres in mouse ESCs. (A) Western blot analyses using antibodies against histone H3.3 and alpha tubulin. H3.3A and H3.3B protein levels are reduced by 30% and 80% in H3f3a−/− and H3f3b−/− mouse ESC clones, respectively. Alpha tubulin was used as loading control for normalization. (B) ChIP-qPCR analysis of H3.3, ATRX, H3K9me3 and H4K20me3 at telomeres in wild-type (WT), H3f3a−/− and H3f3b−/− ESCs. Chromatin was fixed, sonicated and subjected to ChIP with specific antibodies. Each ChIP was performed with 2 μg of antibody pre-bound to Protein A Sepharose. The ChIP products were eluted, purified and subjected to real-time PCR analyses with relevant DNA primers. Y-axis represents relative enrichment over ‘Input’ and Mean ± SD of three replicate experiments are shown. (C) Sequential ChIP-qPCR analysis of H3.3 enrichment in K9me3 at telomeres. H3K9me3 was first ChIPed, followed by re-ChIP of H3.3 from the eluted chromatin-enriched with H3.3K9me3. The ChIP products were eluted, purified and subjected to real-time PCR analyses with relevant DNA primers. (D) Total RNA was purified and subjected to agarose gel electrophoresis and Northern blot analysis using γ-32pATP labeled TTAGGG DNA probe. An increase (by three-fold) in TERRA expression level was detected in H3f3b−/− mouse ESC clones (right panel). The levels of total RNA loaded are shown (left panel).
Figure 1. H3.3 deficiency results in a compromised heterochromatic state at telomeres in mouse ESCs. (A) Western blot analyses using antibodies against histone H3.3 and alpha tubulin. H3.3A and H3.3B protein levels are reduced by 30% and 80% in H3f3a−/− and H3f3b−/− mouse ESC clones, respectively. Alpha tubulin was used as loading control for normalization. (B) ChIP-qPCR analysis of H3.3, ATRX, H3K9me3 and H4K20me3 at telomeres in wild-type (WT), H3f3a−/− and H3f3b−/− ESCs. Chromatin was fixed, sonicated and subjected to ChIP with specific antibodies. Each ChIP was performed with 2 μg of antibody pre-bound to Protein A Sepharose. The ChIP products were eluted, purified and subjected to real-time PCR analyses with relevant DNA primers. Y-axis represents relative enrichment over ‘Input’ and Mean ± SD of three replicate experiments are shown. (C) Sequential ChIP-qPCR analysis of H3.3 enrichment in K9me3 at telomeres. H3K9me3 was first ChIPed, followed by re-ChIP of H3.3 from the eluted chromatin-enriched with H3.3K9me3. The ChIP products were eluted, purified and subjected to real-time PCR analyses with relevant DNA primers. (D) Total RNA was purified and subjected to agarose gel electrophoresis and Northern blot analysis using γ-32pATP labeled TTAGGG DNA probe. An increase (by three-fold) in TERRA expression level was detected in H3f3b−/− mouse ESC clones (right panel). The levels of total RNA loaded are shown (left panel).CC BY-NC · PubMed Central
Figure 2. H3.3 is targeted for K9me3 in mouse ESCs. (A) Protein immunoprecipitations with antibodies against ATRX, DAXX, SETDB1 and SUV39H1/2, followed by western blot analysis with an antibody against H3.3. (B) Protein immunoprecipitations with antibodies against H3.3, H3K9me1, H3K9me3 and H3K4me3, followed by western blot analysis with antibodies against H3.3 and H3, respectively. (C) Protein immunoprecipitations with antibodies against H3.3, H3K9me1, H3K9me3, ATRX and DAXX, followed by western blot analysis with an antibody against ATRX. (D and E) Protein immunoprecipitation was performed in both non-nucleosomal and nucleosomal lysates. In (D), antibodies against H3K9me1, H3K9me3 and H3K9ac were used in protein immunoprecipitation, followed by western blot analysis with an antibody against H3.3. In (E), antibodies against ATRX and DAXX were used in protein immunoprecipitation, followed by western blot analysis with antibodies against H3K9me1 and H3K9me3, respectively. (F and G) ChIP-qPCR analyses of H3K9me3, H3.3 and H3 at the telomeres. The results show reduced levels of H3K9me3 and H3.3 at the telomeres in Suv39h1/Suv39h2 (F) and Setdb1 (G) siRNA-depleted ESCs. ‘Con’ refers to control siRNA. Y-axis represents relative enrichment after normalization against H3 ChIP. (H) ChIP/qPCR of H3K9me1, H3K9me3 and H3 at telomeres in H3f3b−/− ESCs expressing either myc-H3.3 (H3.3) or a myc-H3.3K9A mutant (H3.3K9A). Y-axis represents relative enrichment after normalization against H3 ChIP. Cells transfected with myc-H3.3 show a greater increase in H3K9me3, compared to cells transfected with myc-H3.3K9A mutant. (I) ChIP/re-ChIP qPCR of myc/H3.3 and H3.3/H3K9me3 at telomeres in H3f3b−/− ESCs (NT, non-transfected control) with overexpression of either myc-H3.3 (H3.3) or mutant myc-H3.3K9A (H3.3K9A). (Left) Cells were ChIPed with IgG or anti-Myc antibody, followed by re-ChIPed with an antibody against H3.3. (Right) Cells were ChIPed first with IgG or anti-H3K9me3 antibody, followed by re-ChIPed with an antibody against H3.3. Cells transfected with myc-H3.3 show a greater increase in H3K9me3/H3.3 ChIP/re-ChIP, compared to cells transfected with myc-H3.3K9A mutant.
Figure 2. H3.3 is targeted for K9me3 in mouse ESCs. (A) Protein immunoprecipitations with antibodies against ATRX, DAXX, SETDB1 and SUV39H1/2, followed by western blot analysis with an antibody against H3.3. (B) Protein immunoprecipitations with antibodies against H3.3, H3K9me1, H3K9me3 and H3K4me3, followed by western blot analysis with antibodies against H3.3 and H3, respectively. (C) Protein immunoprecipitations with antibodies against H3.3, H3K9me1, H3K9me3, ATRX and DAXX, followed by western blot analysis with an antibody against ATRX. (D and E) Protein immunoprecipitation was performed in both non-nucleosomal and nucleosomal lysates. In (D), antibodies against H3K9me1, H3K9me3 and H3K9ac were used in protein immunoprecipitation, followed by western blot analysis with an antibody against H3.3. In (E), antibodies against ATRX and DAXX were used in protein immunoprecipitation, followed by western blot analysis with antibodies against H3K9me1 and H3K9me3, respectively. (F and G) ChIP-qPCR analyses of H3K9me3, H3.3 and H3 at the telomeres. The results show reduced levels of H3K9me3 and H3.3 at the telomeres in Suv39h1/Suv39h2 (F) and Setdb1 (G) siRNA-depleted ESCs. ‘Con’ refers to control siRNA. Y-axis represents relative enrichment after normalization against H3 ChIP. (H) ChIP/qPCR of H3K9me1, H3K9me3 and H3 at telomeres in H3f3b−/− ESCs expressing either myc-H3.3 (H3.3) or a myc-H3.3K9A mutant (H3.3K9A). Y-axis represents relative enrichment after normalization against H3 ChIP. Cells transfected with myc-H3.3 show a greater increase in H3K9me3, compared to cells transfected with myc-H3.3K9A mutant. (I) ChIP/re-ChIP qPCR of myc/H3.3 and H3.3/H3K9me3 at telomeres in H3f3b−/− ESCs (NT, non-transfected control) with overexpression of either myc-H3.3 (H3.3) or mutant myc-H3.3K9A (H3.3K9A). (Left) Cells were ChIPed with IgG or anti-Myc antibody, followed by re-ChIPed with an antibody against H3.3. (Right) Cells were ChIPed first with IgG or anti-H3K9me3 antibody, followed by re-ChIPed with an antibody against H3.3. Cells transfected with myc-H3.3 show a greater increase in H3K9me3/H3.3 ChIP/re-ChIP, compared to cells transfected with myc-H3.3K9A mutant.CC BY-NC · PubMed Central
Figure 3. H3.3K9 is required for heterochromatin formation and chromatin integrity at telomeres in mouse ESCs. (A–C) WT and H3f3b−/− ESCs were subjected to with (‘G4’) or without (‘Con’) a 6-day treatment with 2 μM TMPYP4. Immunofluorescence (A and C) and CO-FISH (B; refer to Supplementary Figure S5 for examples) analyses were performed to detect TIF (telomeric foci with positive of γ-H2Ax staining) (A and C) and t-SCE (B). (A) H3f3b−/− ESCs show a greater increase cell population with ≥5 TIF per cell, compared to WT cells subjected to 6-day treatment with 2 μM TMPYP4 (examples of an increase in TIF formation are shown in (C)). Mean ± SD of three replicate experiments are shown. (B) H3f3b−/− cells show a greater increase in t-SCE, when compared to WT cells. And, an overexpression of WT myc-H3.3 (‘rescue’) in H3f3b−/− cells results in reduced t-SCE levels compared to overexpression of myc-H3.3K9 mutant. Y-axis represents an average number of t-SCE events per metaphase spread in a total of 35 cells examined. (D) ChIP analyses were performed using antibodies against ATRX, H3.3, H3K9me3 and H4K20me3, followed by qPCR analyses. Increased levels of ATRX, H3.3, H3K9me3 and H4K20me3 are found at telomeres in WT, H3f3a−/− and H3f3b−/− ESCs following 6 h TMPYP4 treatment (G4). Lower increases are detected in H3f3a−/− and H3f3b−/− cells. Y-axis represents relative enrichment to Input DNA.
Figure 3. H3.3K9 is required for heterochromatin formation and chromatin integrity at telomeres in mouse ESCs. (A–C) WT and H3f3b−/− ESCs were subjected to with (‘G4’) or without (‘Con’) a 6-day treatment with 2 μM TMPYP4. Immunofluorescence (A and C) and CO-FISH (B; refer to Supplementary Figure S5 for examples) analyses were performed to detect TIF (telomeric foci with positive of γ-H2Ax staining) (A and C) and t-SCE (B). (A) H3f3b−/− ESCs show a greater increase cell population with ≥5 TIF per cell, compared to WT cells subjected to 6-day treatment with 2 μM TMPYP4 (examples of an increase in TIF formation are shown in (C)). Mean ± SD of three replicate experiments are shown. (B) H3f3b−/− cells show a greater increase in t-SCE, when compared to WT cells. And, an overexpression of WT myc-H3.3 (‘rescue’) in H3f3b−/− cells results in reduced t-SCE levels compared to overexpression of myc-H3.3K9 mutant. Y-axis represents an average number of t-SCE events per metaphase spread in a total of 35 cells examined. (D) ChIP analyses were performed using antibodies against ATRX, H3.3, H3K9me3 and H4K20me3, followed by qPCR analyses. Increased levels of ATRX, H3.3, H3K9me3 and H4K20me3 are found at telomeres in WT, H3f3a−/− and H3f3b−/− ESCs following 6 h TMPYP4 treatment (G4). Lower increases are detected in H3f3a−/− and H3f3b−/− cells. Y-axis represents relative enrichment to Input DNA.CC BY-NC · PubMed Central
Figure 4. H3.3 deficient ESCs are sensitive to the induction of nucleosome disruption. Immunofluorescence analysis was performed to detect the presence of TIF (indicated by positive γ-H2Ax staining at telomeres) following 96 h siRNA-depletion of either Asf1a/b alone or a combined Atrx and Asf1a/b in both WT and H3f3b−/− ESCs. (A) WT ESCs subjected to a combined Atrx and Asf1a/b siRNA depletion (for 96 h) show a much greater increase in cell population with ≥5 TIF per cell, compared to ESCs subjected to a single Asf1a/b siRNA depletion (for 96 h). In the H3f3b−/− background, cells subjected to a single Asf1a/b siRNA depletion show a comparable increase in the level of cell population with ≥5 TIF per cell when compared to cells subjected to a combined Atrx and Asf1a/b siRNA depletion. These levels of increase in TIF in H3f3b−/− cells are also similar to those detected in WT ESCs subjected to a combined Atrx and Asf1a/b siRNA depletion. Examples of TIF on metaphase chromosomes are shown in (B). In parallel, CO-FISH was performed to assess t-SCE activity (A). In WT background, a combined siRNA depletion of Atrx and Asf1a/b results in a further increase in t-SCE compared to a single Asf1a/b siRNA depletion alone. In the H3f3b−/− background, cells subjected to a single Asf1a/b siRNA depletion show a comparable increase in t-SCE when compared to cells subjected to a combined Atrx and Asf1a/b siRNA depletion. The levels of increase in t-SCE in H3f3b−/− cells subjected to a single Asf1a/b siRNA depletion are also similar to that detected in WT ESCs subjected to a combined Atrx and Asf1a/b siRNA depletion.
Figure 4. H3.3 deficient ESCs are sensitive to the induction of nucleosome disruption. Immunofluorescence analysis was performed to detect the presence of TIF (indicated by positive γ-H2Ax staining at telomeres) following 96 h siRNA-depletion of either Asf1a/b alone or a combined Atrx and Asf1a/b in both WT and H3f3b−/− ESCs. (A) WT ESCs subjected to a combined Atrx and Asf1a/b siRNA depletion (for 96 h) show a much greater increase in cell population with ≥5 TIF per cell, compared to ESCs subjected to a single Asf1a/b siRNA depletion (for 96 h). In the H3f3b−/− background, cells subjected to a single Asf1a/b siRNA depletion show a comparable increase in the level of cell population with ≥5 TIF per cell when compared to cells subjected to a combined Atrx and Asf1a/b siRNA depletion. These levels of increase in TIF in H3f3b−/− cells are also similar to those detected in WT ESCs subjected to a combined Atrx and Asf1a/b siRNA depletion. Examples of TIF on metaphase chromosomes are shown in (B). In parallel, CO-FISH was performed to assess t-SCE activity (A). In WT background, a combined siRNA depletion of Atrx and Asf1a/b results in a further increase in t-SCE compared to a single Asf1a/b siRNA depletion alone. In the H3f3b−/− background, cells subjected to a single Asf1a/b siRNA depletion show a comparable increase in t-SCE when compared to cells subjected to a combined Atrx and Asf1a/b siRNA depletion. The levels of increase in t-SCE in H3f3b−/− cells subjected to a single Asf1a/b siRNA depletion are also similar to that detected in WT ESCs subjected to a combined Atrx and Asf1a/b siRNA depletion.CC BY-NC · PubMed Central
Figure 5. A model depicting H3.3 loading by ATRX to establish heterochromatin at telomeres. At nucleosomal disrupted sites such as those that form as a consequence of replication stall, transcription and nucleosomal dysfunction at telomeric repeats, ATRX loads H3.3 to facilitate re-chromatinization of DNA. H3.3 can be mono-methylated prior to its loading and K9 trimethylation at telomeres. This H3.3K9me mark is essential for chromatin repression at telomeres. In the absence of ATRX and H3.3, there will be prolonged nucleosomal disruption at these sites within the telomeric repeats. This may consequently lead to chromatin de-repression and damage at telomeres.
Figure 5. A model depicting H3.3 loading by ATRX to establish heterochromatin at telomeres. At nucleosomal disrupted sites such as those that form as a consequence of replication stall, transcription and nucleosomal dysfunction at telomeric repeats, ATRX loads H3.3 to facilitate re-chromatinization of DNA. H3.3 can be mono-methylated prior to its loading and K9 trimethylation at telomeres. This H3.3K9me mark is essential for chromatin repression at telomeres. In the absence of ATRX and H3.3, there will be prolonged nucleosomal disruption at these sites within the telomeric repeats. This may consequently lead to chromatin de-repression and damage at telomeres.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 62 references

Cited by

Items 101–109 of 109

Metadata

Authors
Udugama, M., Chang, F. T. M., Chan, F. L., Tang, M. C., Pickett, H. A., McGhie, J. D. R., Mayne, L., Collas, P., Mann, J. R., & Wong, L. H.
Affiliations
  • Monash University (AU)
  • The University of Melbourne (AU)
  • The University of Sydney (AU)
  • University of Oslo (NO)
Corresponding author
Wong, Lee H.
Venue
Nucleic Acids Research
Published
2015-08-24
Volume
43
Issue
21
Pages
gkv847
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W1845992880
Cited by
109
References
62
Citations by year
2026: 2 · 2025: 5 · 2024: 9 · 2023: 11 · 2022: 8 · 2021: 13 · 2020: 12 · 2019: 13 · 2018: 7 · 2017: 15 · 2016: 13 · 2015: 1
FWCI
5.21
Type
journal article
Language
en
Open access
Locations
  • Nucleic Acids Research (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Monash University Research Portal (Monash University) (submittedVersion, cc-by-nc)
Funders
  • Medical Research Council
  • National Health and Medical Research Council
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
Keywords
histone H3.3, H3K9 trimethylation, telomeres, heterochromatin assembly, ATRX, H3F3A, H3F3B, H4K20 trimethylation, sister chromatid exchange, G-quadruplex, Asf1, mouse embryonic stem cells
MeSH terms
Animals, Cells, Cultured, DNA Damage, Heterochromatin, Histones, Lysine, Methylation, Sister Chromatid Exchange, Transcription, Genetic, Telomere, Gene Deletion, Histone Code, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.